Coya Therapeutics, Inc.COYANASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank20
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-10.74M
↓ 47% vs avg
Percentile
P20
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
$-7.29M
Historical baseline
PeriodValueYoY Change
2025$-10.74M-4.4%
2024$-10.29M+8.0%
2023$-11.19M-54.6%
2022$-7.24M-85.5%
2021$-3.90M-897.6%
2020$-391266.00-